July 8 (Reuters) - Healthcare Capital Corp HCCC.O :
* ALPHA TAU AND HEALTHCARE CAPITAL CORP. TO COMBINE AND
CREATE A
PUBLICLY TRADED COMPANY FOCUSED ON TRANSFORMING THE TREATMENT OF
SOLID TUMORS THROUGH THE PRECISION DELIVERY OF ALPHA RADIATION
* HEALTHCARE CAPITAL CORP - TRANSACTION REPRESENTS AN
IMPLIED PRO
FORMA EQUITY VALUE OF APPROXIMATELY $1 BILLION
* HEALTHCARE CAPITAL CORP - TRANSACTION IS EXPECTED TO
PROVIDE UP
TO $367 MILLION IN GROSS PROCEEDS
* HEALTHCARE CAPITAL CORP - UPON CLOSING OF BUSINESS
COMBINATION,
ALPHA TAU IS EXPECTED TO BE LISTED ON NASDAQ
* HEALTHCARE CAPITAL CORP - $92 MILLION FULLY-COMMITTED PIPE
IS
ANCHORED BY A COMBINATION OF HEALTHCARE-FOCUSED FINANCIAL AND
STRATEGIC INVESTORS
* HEALTHCARE CAPITAL CORP - ALPHA TAU WILL CONTINUE TO BE
LED BY
ITS CURRENT MANAGEMENT TEAM
* HEALTHCARE CAPITAL CORP - ALL ALPHA TAU SHAREHOLDERS WILL
RETAIN
100% OF THEIR EQUITY HOLDINGS IN PUBLIC COMPANY
* HEALTHCARE CAPITAL CORP - UPON CLOSING, IT IS EXPECTED
THAT HCC
CHAIRMAN DR. DAVID M. MILCH WILL BE APPOINTED TO ALPHA TAU BOARD
OF DIRECTORS
* HEALTHCARE CAPITAL CORP - ALPHA TAU WILL CONTINUE TO BE
LED BY
ITS CURRENT MANAGEMENT TEAM, AND UPON CLOSING
* HEALTHCARE CAPITAL CORP - BUSINESS COMBINATION VALUES
ALPHA TAU
AT AN IMPLIED PRE-MONEY EQUITY VALUE OF $600 MILLION
Source text for Eikon: ID:nPn1m92Vza
Further company coverage: HCCC.O
((Reuters.Briefs@thomsonreuters.com;))